NewslettersPulmonary Cell News Combination of Esomeprazole and Pirfenidone Enhances Antifibrotic Efficacy In Vitro and in a Mouse Model of TGFβ-Induced Lung Fibrosis By Jamie Kang - November 30, 2022 0 Investigators evaluated the anti-fibrotic efficacy of the proton pump inhibitor esomeprazole when combined with pirfenidone in vitro and in vivo. [Scientific Reports] Full Article